Chimicles & Tikellis is investigating a potential class action lawsuit against Conshohocken, Pa.-based Invibio Inc. Invibio supplies some of the world’s largest medical device manufacturers with a high-performance polymer used to make spinal and other medical implants. On April 27, 2016, the Federal Trade Commission announced that it had reached a settlement with Invibio to resolve allegations that the company had used long-term exclusive contracts to maintain a monopoly. In particular, the FTC alleged that Invibio engaged in conduct that restrained competition in the market for implant-grade polyetheretherketone (known as PEEK), and which allowed Invibio to obtain approximately 90% of the PEEK market. While the FTC settlement requires Invibio to take certain measures to stop this anticompetitive conduct going forward, it does not compensate its customers for the amounts by which they were previously overcharged.
If you purchased PEEK products directly from Invibio at any point in the past four years, please contact the attorneys below.